Preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma

Preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma

Glioblastoma (GBM) is resistant to most multimodal therapies. Clinical success of immune-checkpoint inhibitors (ICIs) has spurred interest in applying ICIs targeting CTLA4, PD1 or IDO1 against GBM. This amplifies the need to ascertain GBM's intrinsic susceptibility (or resistance) toward these...

Full description

Bibliographic Details
Main Authors:	Abhishek D. Garg, Lien Vandenberk, Matthias Van Woensel, Jochen Belmans, Marco Schaaf, Louis Boon, Steven De Vleeschouwer, Patrizia Agostinis
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2017-04-01
Series:	OncoImmunology
Subjects:	cancer immunotherapy copy-number alterations (cna) ctla4 high-grade glioma ido1 immune-checkpoint blockers (icbs) mutational burden neoantigen patient prognosis pd1 t cells treg cells
Online Access:	http://dx.doi.org/10.1080/2162402X.2017.1295903

Similar Items

Identification of Neoantigens in Cancer Cells as Targets for Immunotherapy
by: Masahiro Okada, et al.
Published: (2022-02-01)

Commentary: preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma by Garg et al. (2017)
by: Lijie Zhai, et al.
Published: (2019-03-01)

Establishing a prognostic threshold for total copy number variation within adult IDH-mutant grade II/III astrocytomas
by: Kanish Mirchia, et al.
Published: (2019-07-01)

Association of FOSL1 copy number alteration and triple negative breast tumors
by: Leandro Tamião Rodrigues Serino, et al.
Published: (2019-02-01)

Anti-regulatory T cells are natural regulatory effector T cells
by: Niels Ødum
Published: (2019-10-01)

Loss of SMAD4 Is Sufficient to Promote Tumorigenesis in a Model of Dysplastic Barrett’s EsophagusSummary
by: Jovana R. Gotovac, et al.
Published: (2021-01-01)

CNApp, a tool for the quantification of copy number alterations and integrative analysis revealing clinical implications
by: Sebastià Franch-Expósito, et al.
Published: (2020-01-01)

Tolerogenic IDO+ dendritic cells are induced by PD-1-expressing mast cells
by: Cecilia Pessoa Rodrigues, et al.
Published: (2016-01-01)

Epacadostat stabilizes the apo-form of IDO1 and signals a pro-tumorigenic pathway in human ovarian cancer cells
by: Sofia Rossini, et al.
Published: (2024-01-01)

Impact of IDO1 and IDO2 on the B Cell Immune Response
by: Lauren M. F. Merlo, et al.
Published: (2022-04-01)

Curcumin as an Adjuvant to Cancer Immunotherapy
by: Silpita Paul, et al.
Published: (2021-08-01)

Triple Immunotherapy Overcomes Immune Evasion by Tumor in a Melanoma Mouse Model
by: Mary-Ann N. Jallad, et al.
Published: (2020-06-01)

Separated Siamese Twins: Intronic Small Nucleolar RNAs and Matched Host Genes May be Altered in Conjunction or Separately in Multiple Cancer Types
by: Marianna Penzo, et al.
Published: (2020-02-01)

Soluble NKG2D ligands limit the efficacy of immune checkpoint blockade
by: Alejandro López-Soto, et al.
Published: (2017-10-01)

EVALUATION OF THE CONTENT OF CD4+CD25+CD127LOW REGULATORY T CELLS AND THEIR FUNCTIONAL STATUS ACCORDING TO THE EXPRESSION OF CTLA-4 AND CD39 MOLECULES IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: G. A. Zhulai, et al.
Published: (2014-06-01)

A Cyclic Permutation Approach to Removing Spatial Dependency between Clustered Gene Ontology Terms
by: Rachel Rapoport, et al.
Published: (2024-03-01)

Rare Tumor-Normal Matched Whole Exome Sequencing Identifies Novel Genomic Pathogenic Germline and Somatic Aberrations
by: Ryan Sprissler, et al.
Published: (2020-06-01)

Profile of atezolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectives
by: Facchinetti F, et al.
Published: (2018-09-01)

Stem Cell Origin of Cancer: Implications of Oncogenesis Recapitulating Embryogenesis in Cancer Care
by: Shi-Ming Tu, et al.
Published: (2023-04-01)

Review of the Immune Checkpoint Inhibitors in the Context of Cancer Treatment
by: Norah A. Alturki
Published: (2023-06-01)

Next-generation immuno-oncology agents: current momentum shifts in cancer immunotherapy
by: Chongxian Pan, et al.
Published: (2020-04-01)

IDO1 can impair NK cells function against non-small cell lung cancer by downregulation of NKG2D Ligand via ADAM10
by: Xin Fang, et al.
Published: (2022-03-01)

Genetic Polymorphisms Affecting IDO1 or IDO2 Activity Differently Associate With Aspergillosis in Humans
by: Valerio Napolioni, et al.
Published: (2019-05-01)

Machine learning-based genome-wide interrogation of somatic copy number aberrations in circulating tumor DNA for early detection of hepatocellular carcinoma
by: Kaishan Tao, et al.
Published: (2020-06-01)

The Effect of TGF-β on Treg Cells in Adverse Pregnancy Outcome upon Toxoplasma gondii Infection
by: Mingdong Zhao, et al.
Published: (2017-05-01)

The increased ratio of Treg/Th2 in promoting metastasis of hepatocellular carcinoma
by: Chuanzhi Li, et al.
Published: (2022-04-01)

Neo‐Antigen‐Reactive T Cells Immunotherapy for Colorectal Cancer: A More Personalized Cancer Therapy Approach
by: Guan‐Liang Chen, et al.
Published: (2023-11-01)

Beneficial or detrimental activity of regulatory T cells, indoleamine 2,3-dioxygenase, and heme oxygenase-1 in the lungs is influenced by the level of virulence of Mycobacterium tuberculosis strain infection
by: Vasti Lozano-Ordaz, et al.
Published: (2023-05-01)

Th17/Treg imbalance is associated with reduced indoleamine 2,3 dioxygenase activity in childhood allergic asthma
by: Ying Hu, et al.
Published: (2020-07-01)

Regulatory T Cells Improved the Anti-cirrhosis Activity of Human Amniotic Mesenchymal Stem Cell in the Liver by Regulating the TGF-β-Indoleamine 2,3-Dioxygenase Signaling
by: Zhenhua Deng, et al.
Published: (2021-10-01)

Pregnancy and lactation interfere with the response of autoimmunity to modulation of gut microbiota
by: Qinghui Mu, et al.
Published: (2019-07-01)

Sodium Tanshinone IIA Sulfonate as a Potent IDO1/TDO2 Dual Inhibitor Enhances Anti-PD1 Therapy for Colorectal Cancer in Mice
by: Rongjie Zhang, et al.
Published: (2022-04-01)

Faecalibacterium prausnitzii Skews Human DC to Prime IL10-Producing T Cells Through TLR2/6/JNK Signaling and IL-10, IL-27, CD39, and IDO-1 Induction
by: Joudy Alameddine, et al.
Published: (2019-02-01)

Recent progress in the field of cycloaddition reactions involving conjugated nitroalkenes
by: Agnieszka Łapczuk-Krygier, et al.
Published: (2019-01-01)

CTLA-4 antibody-drug conjugate reveals autologous destruction of B-lymphocytes associated with regulatory T cell impairment
by: Musleh M Muthana, et al.
Published: (2023-12-01)

Alleviating psoriatic skin inflammation through augmentation of Treg cells via CTLA-4 signaling peptide
by: Woo-Sung Lee, et al.
Published: (2023-09-01)

Plasmacytoid Dendritic Cells Protect Against Middle Cerebral Artery Occlusion Induced Brain Injury by Priming Regulatory T Cells
by: Chen Chen, et al.
Published: (2020-01-01)

CNA Profiling of Single CTCs in Locally Advanced Esophageal Cancer Patients during Therapy Highlights Unexplored Molecular Pathways
by: Giulia Gallerani, et al.
Published: (2021-12-01)

The targeting of tumor-associated macrophages by vaccination
by: Mads Hald Andersen
Published: (2019-04-01)

Inhibition of indoleamine 2,3-dioxygenase 1 synergizes with oxaliplatin for efficient colorectal cancer therapy
by: Xiaofei Miao, et al.
Published: (2021-03-01)